| Date Filed | Type | Description |
| 08/07/2023 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
| 05/25/2023 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Exercised 9,324 restricted stock units
@ $0
Granted 8,663 restricted stock units
@ $0 |
|
| 10/31/2022 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 4,149 shares
@ $0 |
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2022 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 7,000 options to buy
@ $12.89, valued at
$90.2k
Granted 2,000 restricted stock units
@ $0 |
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2021 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,402 shares
@ $0 |
|
| 08/12/2021 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $25.05, valued at
$501k
|
|
| 08/12/2021 |
3
| Crane Rosemary A (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2020 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 2,125 shares
@ $0 |
|
| 08/28/2020 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 661 shares
@ $0 |
|
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Exercised 17,621 options to buy
@ $0 |
|
| 06/11/2020 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Granted 12,668 options to buy
@ $0 |
|
| 08/26/2019 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 3,167 shares
@ $0 |
|
| 06/13/2019 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Granted 17,621 options to buy
@ $0 |
|
| 05/20/2019 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Exercised 2,780 options to buy
@ $0 |
|
| 03/18/2019 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Exercised 10,000 restricted stock units
@ $0 |
|
| 09/05/2018 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Exercised 2,162 options to buy
@ $0 |
|
| 08/24/2018 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 4,183 shares
@ $0 |
|
| 08/15/2018 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 06/20/2018 |
4
| Crane Rosemary A (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.1, valued at
$22k
|
|
| 06/07/2018 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Granted 6,041 options to buy
@ $0 |
|
| 01/02/2018 |
3
| Crane Rosemary A (Director) has filed a Form 3 on TEVA PHARMACEUTICAL INDUSTRIES LTD |
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/07/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/06/2014 |
4
| Crane Rosemary A (CEO and President) has filed a Form 4 on MELA SCIENCES, INC. /NY|
Txns:
| Bought 67,570 shares
@ $0.74, valued at
$50k
|
|
| 11/13/2013 |
4
| Crane Rosemary A (CEO and President) has filed a Form 4 on MELA SCIENCES, INC. /NY|
Txns:
| Granted 400,000 options
@ $0.7, valued at
$280k
|
|
|